MindWalk Holdings Corp. Logo

MindWalk Holdings Corp.

A Bio-Native AI company that integrates AI and lab research for drug discovery.

HYFT | US

Overview

Corporate Details

ISIN(s):
CA45257F2008
LEI:
Country:
United States of America
Address:
INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300, 78701 AUSTIN

Description

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MindWalk Holdings Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MindWalk Holdings Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MindWalk Holdings Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ProQR Therapeutics N.V. Logo
Develops RNA therapies for severe genetic disorders using its RNA editing platform.
United States of America
PRQR
Prostatype Genomics AB Logo
Develops a genetic test that assesses prostate cancer aggressiveness to guide treatment.
Sweden
PROGEN
Protagenic Therapeutics, Inc.\new Logo
Develops peptide-based therapeutics for stress-related neuropsychiatric disorders.
United States of America
PTIX
Protara Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for cancer and rare diseases.
United States of America
TARA
PROTEINA CO.,LTD. Logo
A biotech firm analyzing protein interactions for drug and diagnostic development.
South Korea
468530
PROTEOME SCIENCES PLC Logo
A Contract Research Organization focused on applied proteomics and peptidomics services.
United Kingdom
PRM
PROTHENA CORP PUBLIC LTD CO Logo
Biotechnology company developing therapies for diseases of protein dysregulation.
United States of America
PRTA
PROVEXIS PLC Logo
Develops and licenses functional ingredients for the food and supplement markets.
United Kingdom
PXS
Psomagen, Inc. Logo
A contract lab providing multiomics and data analysis solutions for researchers.
United States of America
950200
Psych Capital Plc Logo
Biopharmaceutical company developing psilocybin-based therapy for anorexia nervosa.
United Kingdom
PSY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.